BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9413105)

  • 1. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge.
    Bruschke CJ; Moormann RJ; van Oirschot JT; van Rijn PA
    Vaccine; 1997 Dec; 15(17-18):1940-5. PubMed ID: 9413105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep.
    Bruschke CJ; van Oirschot JT; van Rijn PA
    Vaccine; 1999 Apr; 17(15-16):1983-91. PubMed ID: 10217598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes.
    Carlsson U; Alenius S; Sundquist B
    Vaccine; 1991 Aug; 9(8):577-80. PubMed ID: 1663302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies.
    Bruschke CJ; van Rijn PA; Moormann RJ; van Oirschot JT
    Vet Microbiol; 1996 May; 50(1-2):33-43. PubMed ID: 8810006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
    J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine.
    Brownlie J; Clarke MC; Hooper LB; Bell GD
    Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection of pregnant ewes with bovine viral diarrhea virus type-2 (BVDV-2): effects on the pregnancy and fetus.
    Scherer CF; Flores EF; Weiblen R; Caron L; Irigoyen LF; Neves JP; Maciel MN
    Vet Microbiol; 2001 Apr; 79(4):285-99. PubMed ID: 11267789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle.
    Chimeno Zoth S; Leunda MR; Odeón A; Taboga O
    Braz J Med Biol Res; 2007 Jun; 40(6):813-8. PubMed ID: 17581680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
    Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination.
    Patel JR; Shilleto RW; Williams J; Alexander DC
    Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal protection against bovine viral diarrhoea type 1 virus infection after one administration of a live-attenuated vaccine.
    Meyer G; Deplanche M; Roux D; Moulignie M; Picard-Hagen N; Lyazrhi F; Raboisson D; Mathevet P; Schelcher F
    Vet J; 2012 May; 192(2):242-5. PubMed ID: 21689959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foetal protection against bovine virus diarrhoea virus after two-step vaccination.
    Frey HR; Eicken K; Grummer B; Kenklies S; Oguzoglu TC; Moennig V
    J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):489-93. PubMed ID: 12485359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines.
    Brock KV; Chase CC
    Vet Microbiol; 2000 Nov; 77(1-2):209-14. PubMed ID: 11042414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.